Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mitsubishi Corporation

https://www.mhi-global.com

Latest From Mitsubishi Corporation

Stalicla Seals Deal To Advance Novartis Drug For Cocaine Misuse

The biotech has persuaded its fellow Swiss firm that it can advance mavoglurant, a Novartis drug that has failed in Parkinson’s and Fragile X syndrome, for cocaine use and neurodevelopmental disorders.

Deals Neurology

Deal Watch: Aging-Focused Calico Taps Start-Up Terray For Discovery

Terray/Calico tie-up will focus on small molecule discovery for diseases of aging, including cancer. Lilly, AstraZeneca sign discovery pacts with Nimbus and Illumina, respectively.

Deal Watch Business Strategies

Japan's Price Cuts Slated For April Bring Old, New Blues For Industry

Next month’s regular reimbursement price cut in Japan includes some large reductions for big-selling drugs, while one new rule has been applied for the first time.

Japan Policy

Asahi Paying $1.3bn For One-Product Veloxis

Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.

M & A Business Strategies
See All

Company Information

  • Industry
  • Distributors
  • Diversified
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Diamond Distributed Energy Investments, LLC
    • Japan Medicalnext Co., Ltd.
    • MC Healthcare, Inc.
UsernamePublicRestriction

Register